ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit.
Keith
K
Wheatley
Richard
R
Gray
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000191:economics; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic / Q000191:economics / Q000592:standards; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D017239:Paclitaxel / Q000008:administration & dosage; D017671:Platinum Compounds / Q000008:administration & dosage; D012107:Research Design / Q000592:standards; D016019:Survival Analysis; D016896:Treatment Outcome
D017671:Platinum Compounds; D017239:Paclitaxel; D002945:Cisplatin